Martinrea International (MRE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Nov, 2025Executive summary
Q3 2025 sales were $1,190.8 million, down 3.8% year-over-year, with production sales nearly flat and tooling sales down 54.9%.
Adjusted operating income was $65 million (5.5% margin), up 20 basis points year-over-year, driven by operational improvements and lower depreciation.
Adjusted net EPS rose to $0.52 from $0.19, reflecting improved margins, lower finance expense, and a lower effective tax rate.
Free cash flow was $44.5 million, down from $57 million, mainly due to delayed receivables after a customer cyberattack, but collections have since occurred.
Recognized for advancing women in manufacturing and investing in employee development programs.
Financial highlights
Adjusted operating income for Q3 was $65 million, margin improved to 5.5%, up 20 basis points year-over-year.
Adjusted net EPS rose to $0.52 from $0.19 in Q3 2024.
Free cash flow before IFRS 16 lease payments was $44.5 million, down from $57 million last year.
Net debt (ex-IFRS 16) decreased by $24 million to $768 million; net debt to adjusted EBITDA at 1.5.
Gross margin for Q3 increased to 14.3% from 13.2% year-over-year.
Outlook and guidance
2025 outlook maintained: total sales of $4.8–$5.1 billion, adjusted operating income margin of 5.3–5.8%, and free cash flow of $125–$175 million.
Expecting to finish 2025 near the high end of free cash flow guidance.
Operating margins expected to improve year-over-year in 2026, driven by efficiency gains and commercial settlements.
North American production assumed flat for 2025–2026 at 14.5–14.7 million units, with potential upside from reshoring.
Outlook excludes impacts of tariffs and government policy changes, and anticipates $55 million in cash restructuring costs for 2025.
Latest events from Martinrea International
- Record Free Cash Flow and margin gains in 2025 set the stage for continued growth and expansion.MRE
Q4 20255 Mar 2026 - Record Q2 adjusted EBITDA, strong cash flow, and stable 2024 outlook despite industry headwinds.MRE
Q2 20242 Feb 2026 - Q3 saw lower sales and earnings but stronger margins, cash flow, and improved leverage.MRE
Q3 202414 Jan 2026 - Impairments and lower sales drove a net loss, but Free Cash Flow and margins remained resilient.MRE
Q4 20243 Dec 2025 - Sales and margins declined year-over-year, but new awards and cost focus support future outlook.MRE
Q1 202528 Nov 2025 - Margins and free cash flow improved in Q2 2025, with 2025 guidance reaffirmed.MRE
Q2 202523 Nov 2025